{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:38:19Z","timestamp":1792417099740,"version":"4.4.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T00:00:00Z","timestamp":1447027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142290","type":"journal-article","created":{"date-parts":[[2015,11,9]],"date-time":"2015-11-09T13:26:09Z","timestamp":1447075569000},"page":"e0142290","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":97,"title":["Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials"],"prefix":"10.1371","volume":"10","author":[{"given":"Henok Tadesse","family":"Ayele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike S. M. van","family":"Mourik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P. A.","family":"Debray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J. M.","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,9]]},"reference":[{"key":"ref1","first-page":"426","article-title":"The arcana of Tuberculosis with a brief epidemiologic history of the disease in the USA. Part III","volume":"78","author":"E. R. Grigg","year":"1958","journal-title":"Am Rev Tuberc Pulm Dis"},{"issue":"1","key":"ref2","first-page":"142","article-title":"The White Plague, Tuberculosis; Man and Society","volume":"42","author":"I. Galdston","year":"1954","journal-title":"Bull. Med. Libr. Assoc."},{"key":"ref3","first-page":"562","article-title":"Andvord KF 2002 what can we learn by following the development.pdf","volume":"6","author":"F Kristian","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMra1200894","article-title":"Tuberculosis","volume":"368","author":"A. Zumla","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0962-8479(92)90033-G","article-title":"HIV-associated tuberculosis in developing countries: Epidemiology and strategies for prevention","volume":"73","author":"J. P. Narain","year":"1992","journal-title":"Tubercle and Lung Disease"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1086\/515276","article-title":"The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleu","volume":"177","author":"D. Goletti","year":"1998","journal-title":"J. Infect. Dis."},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/381554","article-title":"Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosis","volume":"189","author":"D. Goletti","year":"2004","journal-title":"J.Infect.Dis."},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1086\/513438","article-title":"Mechanisms of polymorphonuclear neutrophil-mediated induction of HIV-1 replication in macrophages during pulmonary tuberculosis.","volume":"195","author":"Y. Hoshino","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1084\/jem.20011614","article-title":"Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines.","volume":"195","author":"Y. Hoshino","year":"2002","journal-title":"J. Exp. Med."},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1086\/516494","article-title":"Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells","volume":"175","author":"G. Mancino","year":"1997","journal-title":"J Infect Dis"},{"issue":"7","key":"ref11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006116","article-title":"HIV-1 replication is differentially regulated by distinct clinical strains of Mycobacterium tuberculosis","volume":"4","author":"S. Ranjbar","year":"2009","journal-title":"PLoS One"},{"issue":"7004","key":"ref12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature02837","article-title":"A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response.","volume":"431","author":"M. B. Reed","year":"2004","journal-title":"Nature"},{"issue":"Suppl 2","key":"ref13","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/00002030-200102002-00007","article-title":"Perspectives on inducing efficient immune control of HIV-1 replication\u2014a new goal for HIV therapeutics","volume":"15","author":"R. P. Bucy","year":"2001","journal-title":"AIDS"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/BF02726017","article-title":"Management of opportunistic infections in pediatric HIV.","volume":"69","author":"R. H. Merchant","year":"2002","journal-title":"Indian J. Pediatr."},{"key":"ref15","first-page":"28","article-title":"Controlled chemoprophylaxis trials in tuberculosis: a general review","volume":"26","author":"S. Ferebee","year":"1970","journal-title":"Bibl Tuberc."},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection","volume":"320","author":"P. A. Selwyn","year":"1989","journal-title":"N Engl J Med"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/00002030-199310000-00007","article-title":"A prospective study of the risk of tuberculosis among HIV-infected patients.","volume":"7","author":"A. Guelar","year":"1993","journal-title":"AIDS"},{"issue":"8866","key":"ref18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0140-6736(93)91817-6","article-title":"Effect if isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection","volume":"342","author":"J. W. Pape","year":"1993","journal-title":"Lancet"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMoa1214289","article-title":"A trial of mass isoniazid preventive therapy for tuberculosis control.","volume":"370","author":"G. J. Churchyard","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cct.2010.12.008","article-title":"Thibela TB: Design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa","volume":"32","author":"K. L. Fielding","year":"2011","journal-title":"Contemp. Clin. Trials"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","article-title":"Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected Persons: An International Randomized Trial","volume":"283","author":"F. Gordin","year":"2000","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-119-3-199308010-00003","article-title":"Risk for developing tuberculosis among anergic patients infected with HIV.","volume":"119","author":"S. Moreno","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"ref23","article-title":"Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.","author":"N. M. Graham","year":"1996"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1590\/S0074-02762009000300011","article-title":"Effectiveness and safety of isoniazid chemoprophylaxis for HIV-1 infected patients from Rio de Janeiro.","volume":"104","author":"C. T. V. de Souza","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049928","article-title":"Systematic Review of TST Responses in People Living with HIV in Under-Resourced Settings: Implications for Isoniazid Preventive Therapy","volume":"7","author":"A. D. Kerkhoff","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12879-015-1089-3","article-title":"Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study","volume":"15","author":"H. T. Ayele","year":"2015","journal-title":"BMC Infect. Dis."},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.","volume":"21","author":"J. E. Golub","year":"2007","journal-title":"AIDS"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","article-title":"Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.","volume":"23","author":"J. E. Golub","year":"2009","journal-title":"AIDS"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002030-199903110-00009","article-title":"Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials.","volume":"13","author":"H. C. Bucher","year":"1999","journal-title":"AIDS"},{"issue":"1","key":"ref30","first-page":"171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","author":"C. Akolo","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7159","key":"ref31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.317.7159.625","article-title":"Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials","volume":"317","author":"D. Wilkinson","year":"1998","journal-title":"Bmj"},{"key":"ref32","unstructured":"WHO Stop TB, \u201cINTERIM POLICY ON COLLABORATIVE TB\/HIV ACTIVITIES,\u201d Geneva, Switzerland, 2004."},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2471\/BLT.09.066522","article-title":"Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.","volume":"88","author":"A. A. Date","year":"2010","journal-title":"Bull. World Health Organ."},{"key":"ref34","first-page":"213","article-title":"Three I\u2019s for HIV\/TB and early ART to prevent HIV and TB: Policy review of HIV and TB guidelines for high HIV\/TBburden African countries","volume":"15","author":"S. S. Gupta","year":"2012","journal-title":"J. Int. AIDS Soc."},{"key":"ref35","unstructured":"WHO, \u201cGlobal tuberculosis report 2013,\u201d Geneva, Switzerland, 2013."},{"key":"ref36","unstructured":"World Health Organization, <italic>Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resourceconstrained settings<\/italic>. 2015."},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/(SICI)1521-4036(199912)41:8<901::AID-BIMJ901>3.0.CO;2-W","article-title":"An alternative method for meta-analysis","volume":"41","author":"J. Hartung","year":"1999","journal-title":"Biometrical J."},{"issue":"24","key":"ref38","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/sim.1009","article-title":"A refined method for the meta analysis of controlled CLINICAL TRIALS with binary outcome.","volume":"20","author":"J. Hartung","year":"2001","journal-title":"Stat Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses.","volume":"342","author":"R. D. Riley","year":"2011","journal-title":"BMJ"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2288-9-80","article-title":"Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data.","volume":"9","author":"B. C. Wallace","year":"2009","journal-title":"BMC Med. Res. Methodol."},{"key":"ref41","unstructured":"R Development Core Team, \u201cR: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.R-project.org\/\" xlink:type=\"simple\">http:\/\/www.R-project.org\/<\/ext-link>.,\u201d <italic>R Found. Stat. Comput. Vienna<\/italic>, <italic>Austria<\/italic>., 2012."},{"key":"ref42","article-title":"Global Tuberculosis Report 2013","volume":"375","year":"2013","journal-title":"Global Tuberculosis Report 2013"},{"key":"ref43","first-page":"3","article-title":"Cochrane Handbook: Cochrane Reviews: Ch 8: Assessing risk of bias in included studies","volume":"6","author":"S. Green","year":"2011","journal-title":"Cochrane Handbook for: Systematic Reviews of Interventions"},{"key":"ref44","unstructured":"M. Borenstein, L. Hedges, and H. Rothstein, <italic>Meta-Analysis Fixed effect vs. random effects<\/italic>. 2007."},{"key":"ref45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1473-3099(10)70078-5","article-title":"Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources","volume":"10","author":"S. D. Lawn","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"June","key":"ref46","first-page":"1026","article-title":"HIV-associated tuberculosis in the era of highly active antiretroviral therapy","volume":"4","author":"J. L. Jones","year":"2000","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"13","key":"ref47","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/00002030-200009080-00015","article-title":"Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection.","volume":"14","author":"E. Girardi","year":"2000","journal-title":"AIDS"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy","volume":"34","author":"G. Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"9323","key":"ref49","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.","volume":"359","author":"M. Badri","year":"2002","journal-title":"Lancet"},{"issue":"9","key":"ref50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000826","article-title":"Impact of antiretroviral therapy on the incidence of tuberculosis: The Brazilian experience, 1995\u20132001","volume":"2","author":"A. Miranda","year":"2007","journal-title":"PLoS One"},{"issue":"18","key":"ref51","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/QAD.0b013e3282f1c933","article-title":"Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.","volume":"21","author":"R. Muga","year":"2007","journal-title":"AIDS"},{"issue":"12","key":"ref52","first-page":"1393","article-title":"Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status.","volume":"12","author":"S. Moreno","year":"2008","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.","volume":"20","author":"S. D. Lawn","year":"2006","journal-title":"AIDS"},{"issue":"18","key":"ref54","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.","volume":"19","author":"S. D. Lawn","year":"2005","journal-title":"AIDS"},{"issue":"12","key":"ref55","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","article-title":"Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.","volume":"41","author":"E. Girardi","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1258\/ijsa.2011.011051","article-title":"Predictors of antiretroviral treatment-associated tuberculosis in Ethiopia: a nested case-control study","volume":"23","author":"N. Mesfin","year":"2012","journal-title":"International Journal of STD & AIDS"},{"issue":"13","key":"ref57","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa.","volume":"23","author":"S. D. Lawn","year":"2009","journal-title":"AIDS"},{"issue":"11","key":"ref58","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/01.aids.0000176211.08581.5a","article-title":"How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control.","volume":"19","author":"S. D. Lawn","year":"2005","journal-title":"AIDS (London, England)"},{"issue":"2","key":"ref59","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CMR.00042-10","article-title":"HIV and tuberculosis: a deadly human syndemic.","volume":"24","author":"C. K. Kwan","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"issue":"9777","key":"ref60","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":"6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial.","volume":"377","author":"T. Samandari","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"ref61","first-page":"2010","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","author":"C. Akolo","journal-title":"Treatment of latent tuberculosis infection in HIV infected persons"},{"issue":"180","key":"ref62","doi-asserted-by":"crossref","first-page":"180ra49","DOI":"10.1126\/scitranslmed.3005260","article-title":"Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis.","volume":"5","author":"H. L. Mills","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref63","doi-asserted-by":"crossref","first-page":"c221","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: rationale, conduct, and reporting.","volume":"340","author":"R. D. Riley","year":"2010","journal-title":"BMJ"},{"key":"ref64","article-title":"Methods for Individual Participant Data meta-analysis of relevant treatment effect: a systematic review","author":"TPA Debray","year":"2015","journal-title":"Res Syn Meth."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:52:48Z","timestamp":1588978368000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142290"}},"subtitle":[],"editor":[{"given":"Katalin Andrea","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,9]]},"references-count":64,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142290","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,9]]}}}